Skip to main content
Log in

Dopamine receptors in the developing sheep kidney

  • Proceedings of the Third International Workshop on Developmental Renal Physiology September 6–7, 1986 Tokyo, Japan
  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

These studies were designed to characterize dopamine receptor density and affinity in kidneys removed from sheep of varying ages (fetal, newborn, and adult) using radioligand binding methods. Three different radioligands were used: the specific dopamine-1 antagonist3H-SCH 23390, the dopamine-1/dopamine-2 antagonist3H-haloperidol, and the dopamine-2 antagonist3H-spiroperidol. The specific binding of3H-haloperidol and3H-spiroperidol was saturable with time and ligand concentration, being indicative of dopamine receptors. The specific binding of the dopamine-1 selective radioligand3H-SCH 23390 was also saturable with time but displayed several points of saturation with increasing ligand concentration. The specific binding of3H-haloperidol, which had a low affinity and is indicative of dopamine-1 receptors, showed no age-related changes in maximum receptor density or affinity. On the other hand, the maximum receptor density of dopamine-2 receptors measured by3H-spiroperidol decreased with age. The observations that renal dopamine-1 receptor density or affinity do not change with maturation are in agreement with our pervious studies that showed no age-related changes in dopamine-receptor-mediated renal vasodilatation in sheep. The significance of the decrease in renal dopamine-2 receptor density with age remains to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93–96

    Google Scholar 

  2. Felder RA, Carey RM (1987) Dopamine in cardiovascular function. In: Buckley JP, Ferrario CM (eds) Brain peptides and catecholamines in cardiovascular regulation in normal and disease states. Raven Press, New York, pp 79–91

    Google Scholar 

  3. Missale C, Pizzi M, Memo M, Picotti GB, Carruba MO, Spano PF (1985) Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries. Neurosci Lett 61:207–211

    Google Scholar 

  4. Brodde DE (1982) Vascular dopamine receptors: demonstration and characterization by in vitro studies. Life Sci 31: 289–306

    Google Scholar 

  5. Frederickson E, Bradley T, Goldberg LI (1985) Blockade of renal effects of dopamine in the dog by DA1 antagonist SCH 23390. Am J Physiol 249: F236–F240

    Google Scholar 

  6. Goldberg LI, Volkman PH, Kohli ID (1978) A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol 18: 57–79

    Google Scholar 

  7. Gootman N, Buckley BJ, Gootman PM, Nagelberg JS (1982) Age related effects of single injections of dopamine on cardiovascular function in developing swine. Dev Pharmacol Ther 4: 139–150

    Google Scholar 

  8. Vane DW, Weber TR, Careskey J, Grosfeld JL (1982) Systemic and renal effects of dopamine in the infant pig. J Surg Res 32: 477–483

    Google Scholar 

  9. Pelayo JC, Fildes RD, Jose PA (1984) Age-dependent renal effects of intrarenal dopamine infusion. Am J Physiol 247: R212–R216

    Google Scholar 

  10. Nakamura KT, Felder RA, Jose PA, Robillard JE (1987) Effects of dopamine in the renal vascular bed of fetal, newborn, and adult sheep. Am J Physiol 252: R490–R497

    Google Scholar 

  11. Robillard JE, Weitzman RE (1980) Developmental aspects of the fetal response to exogenous arginine vasopressin. Am J Physiol 238: F407–F414

    Google Scholar 

  12. Felder RA, Blecher M, Eisner GM, Jose PA (1984) Cortical tubular and glomerular dopamine receptors in the rat kidney. Am J Physiol 246: F557–F568

    Google Scholar 

  13. Snavely MD, Insel RA (1982) Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na+. Mol Pharmacol 22: 532–546

    Google Scholar 

  14. Huff RM, Molinoff PB (1982) Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci USA 79: 7561–7565

    Google Scholar 

  15. Christensen AV, Arnt J, Hyttel J, Larsen JJ, Svendsen O (1984) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529–1540

    Google Scholar 

  16. Allesandrini C, Cavalotti C, Rossi M De, Fruschelli C, Gerli R, Mione MC, Sacchi G, Amenta F (1984) Localization of dopamine receptors in the rabbit renal artery: a histoautoradiographic study. Pharmacology 29: 17–23

    Google Scholar 

  17. Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462–468

    Google Scholar 

  18. Niznik HB, Otsuka Y, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P (1986) Dopamine D1 receptors characterized with (3H)SCH 23390. J Biol Chem 261: 8397–8406

    Google Scholar 

  19. Felder RA, Blecher M, Calcagno PL, Jose PA (1984) Dopamine receptors in the proximal tubule of the rabbit. Am J Physiol 247: F499–F505

    Google Scholar 

  20. Rosenthal HE (1967) Graphic methods for the determination and presentation of binding parameters in a complex system. Anal Biochem 20: 525–532

    Google Scholar 

  21. Lowry OH, Rosebrough NS, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193: 265–268

    Google Scholar 

  22. Swann AC, Albers RW (1975). Sodium + potassium activated ATPase of mammalian brain regulation of phosphatase activity. Biochim Biophys Acta 382: 437–456

    Google Scholar 

  23. Bennett JP Jr. (1985) Neurotransmitter, hormone, or drug receptor binding methods. In: Yamamura HI, Enna SJ, Kuhar MJ (eds) Neurotrasmitter receptor binding, 2nd edn. Raven, New York, p 61

    Google Scholar 

  24. Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzyme reaction. Biochem Pharmacol 22: 3099–3108

    Google Scholar 

  25. Altar CA, Marien MR (1987) Picomolar affinity of125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography. J Neurosci 7: 213–222

    Google Scholar 

  26. Schmitz JM, Graham RM, Sagalowsky A, Pettinger WA (1981) Renal alpha-1 and alpha-2 adrenergic receptor: biochemical and pharmacological correlations. J Pharmacol Exp Ther 30: 329–337

    Google Scholar 

  27. Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32: 229–313

    Google Scholar 

  28. Dowling JE, Watling KJ (1981) Dopaminergic mechanisms in the teleost retina. II. Factors affecting the accumulation of cyclic AMP in pieces of intact carp retina. J Neurochem 36: 569–579

    Google Scholar 

  29. Steinhausen M, Weis S, Fleming J, Dussel R, Parekh N (1986) Responses of in vivo renal microvessles to dopamine. Kidney Int 30: 361–370

    Google Scholar 

  30. Plantje JF, Hansen HA, Daus FJ, Stoof JC (1984) The effects of SCH 23390, YM 09151-2, (+)- and (−)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro. Eur J Pharmacol 105: 73–83

    Google Scholar 

  31. Pelayo JC, Fildes RD, Eisner GM, Jose PA (1983) The effects of dopamine blockade on renal sodium excretion. Am J Physiol 245: F247–F253

    Google Scholar 

  32. Chapman BJ, Horn NM, Munday KA, Robertson MJ (1980) The actions of dopamine and of sulpiride on regional blood flows in the rat kidney. J Physiol (Lond) 298: 437–452

    Google Scholar 

  33. McGrath B, Bode K, Luxford A, Howden B, Jablonski P (1985) Effects of dopamine on renal function in the rat isolated perfused kidney. Clin Exp Pharmacol Physiol 12: 343–352

    Google Scholar 

  34. Nakajima T, Naitoh F, Kuruma I (1977) Dopamine-sensitive adenylate cyclase in rat kidney particulate preparation. Eur J Pharmacol 41: 163–169

    Google Scholar 

  35. Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272: 168–171

    Google Scholar 

  36. Willcocks AL, Nahorski SR (1983) Binding of125I-iodohydroxy-benzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta adrenoceptors. Biochem Pharmacol 32: 3311–3319

    Google Scholar 

  37. Jose PA, Felder RA, Robillard JE, Felder CC, Eisner GM (1986) Dopamine-2 receptor in the canine kidney (Abstract). Kidney Int 29: 385

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Felder, R.A., Nakamura, K.T., Robillard, J.E. et al. Dopamine receptors in the developing sheep kidney. Pediatr Nephrol 2, 156–162 (1988). https://doi.org/10.1007/BF00870397

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00870397

Key words

Navigation